30,000 patients a day can continue to rely on nuclear medicine from Petten


A multi-year agreement between NRG and Curium has been signed for the production of Molybdenum-99, the base material for Technetium-99 (Tc 99m) generators. Tc 99m is the most... more

NRG completes the irradiation of special metal for ITER


The Netherlands and Sweden characterise new material to be tested in the biggest fusion device PETTEN, The Netherlands - NRG has completed the irradiation testing of a high-tech... more

Petten invests in new nuclear pharmaceuticals - The Netherlands playing a pioneering role in the development of nuclear medicine


PETTEN, The Netherlands, 17 January 2019 – NRG announced today that the Kansen voor West organisation has awarded a subsidy of €6.8 million to develop FIELD-LAB. This contribution... more

High Flux Reactor back in operation


Update Wednesday 31th of October 2018 more

‘Petten’ starts production of medical isotope xenon-133


Thanks to intensive collaboration between Curium (formerly the nuclear business of Mallinckrodt Pharmaceuticals) and NRG in Petten, a complex project has been brought to a... more

Xenonverpakking eindproduct